Back to Delaware

HB156 • 2025

AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE HEALTHCARE ASSOCIATED INFECTIONS DISCLOSURE ACT.

AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE HEALTHCARE ASSOCIATED INFECTIONS DISCLOSURE ACT.

Healthcare
Enacted

This bill passed the Legislature and reached final enactment based on the latest official action.

Sponsor
Burns
Last action
2025-08-25
Official status
Signed 8/25/25
Effective date
Not listed

Plain English Breakdown

The bill summary and official text do not specify when it will take effect after being signed by the Governor.

Healthcare-Associated Infections Disclosure Act Update

This act updates Delaware's Healthcare-Associated Infections Disclosure Act to use correct terminology, align with CDC standards, and make technical corrections.

What This Bill Does

  • Updates the names of facilities in the law to match current terms, such as changing 'psychiatric facility' to 'behavioral health facility'.
  • Requires healthcare facilities to report infections using definitions from the Centers for Disease Control and Prevention (CDC).
  • Makes technical changes to ensure the law follows Delaware's rules for writing laws.

Who It Names or Affects

  • Healthcare facilities in Delaware, including hospitals, long-term care centers, and behavioral health facilities.
  • The Department of Health and Social Services which oversees the reporting requirements.

Terms To Know

Behavioral health facility
A place that provides mental health services for people with mental illness under a doctor's supervision.
Centers for Disease Control and Prevention (CDC)
An agency of the U.S. government that works to protect public health by preventing and controlling diseases, injuries, and disabilities.

Limits and Unknowns

  • The bill does not specify when it will take effect after being signed by the Governor.
  • It is unclear what specific changes were made in technical corrections without seeing the full text of those amendments.

Bill History

  1. 2025-08-25 Delaware General Assembly

    Signed by Governor

  2. 2025-06-26 Delaware General Assembly

    Passed By Senate. Votes: 21 YES

  3. 2025-06-18 Delaware General Assembly

    Reported Out of Committee (Health & Social Services) in Senate with 1 Favorable, 4 On Its Merits

  4. 2025-06-10 Delaware General Assembly

    Passed By House. Votes: 40 YES 1 ABSENT

  5. 2025-06-10 Delaware General Assembly

    Assigned to Health & Social Services Committee in Senate

  6. 2025-05-21 Delaware General Assembly

    Reported Out of Committee (Health & Human Development) in House with 2 Favorable, 9 On Its Merits

  7. 2025-05-08 Delaware General Assembly

    Introduced and Assigned to Health & Human Development Committee in House

Official Summary Text

AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE HEALTHCARE ASSOCIATED INFECTIONS DISCLOSURE ACT.
This Act updates Chapter 10A of Title 16, the Healthcare-Associated Infections Disclosure Act, to ensure consistency with correct terminology, such as psychiatric changes to behavioral health facilities and to adherence to Centers for Disease Control and Prevention (CDC) National Healthcare Safety Network (NHSN) requirements.
This Act also makes technical corrections to conform existing law to the standards of the Delaware Legislative Drafting Manual.

Current Bill Text

Read the full stored bill text
Legislation Document

SPONSOR:

Rep. Burns & Sen. Seigfried

Reps. Chukwuocha, K. Johnson, Morrison; Sen. Walsh

HOUSE OF REPRESENTATIVES

153rd GENERAL ASSEMBLY

HOUSE BILL NO. 156

AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE HEALTHCARE ASSOCIATED INFECTIONS DISCLOSURE ACT.

BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF DELAWARE:

Section 1. Amend Chapter 10A, Title 16 of the Delaware Code by making deletions as shown by strike through and insertions as shown by underline as follows and by redesignating accordingly:

Chapter 10A.

HEALTH-CARE

HEALTHCARE

ASSOCIATED INFECTIONS DISCLOSURE ACT

§ 1001A. Short title.

This chapter may be cited as the “

Health-care

Healthcare

Associated Infections Disclosure Act.”

§ 1002A. Definitions.

For purposes of this chapter:

(1) “Advisory Committee” means the Committee established under this chapter.

(10)

(2)

“

Psychiatric

Behavioral health

facility” means a facility that is primarily engaged in providing, by or under the supervision of a doctor of medicine or osteopathy, psychiatric services for the diagnosis and treatment of

mentally ill persons.

persons with a mental illness.

(2)

(3)

“Correctional

healthcare

facility” means any

health-care

healthcare

facility operated at any Department of Correction facility in this State.

(3)

(4)

“Department” means the Department of Health and Social Services.

(4)

(5)

“Dialysis center” means a facility approved to furnish outpatient dialysis services directly to end stage renal disease (ESRD) patients. Outpatient dialysis includes:

a.

staff-assisted

Staff-assisted

dialysis (dialysis performed by the staff of the

facility)

facility);

and

b.

self-dialysis

Self-dialysis

(dialysis performed with little or no professional assistance by an ESRD patient who has completed an appropriate course of training). ESRD is that stage of renal impairment that appears irreversible and

permanent,

permanent

and requires a regular course of dialysis or kidney transplantation to maintain life.

(5)

(6)

“Freestanding surgical center” means a facility licensed under Chapter 1 of this title.

(6)

(7)

“

Health-care

Healthcare

associated infection” means a localized or systemic condition:

a. That results from adverse reaction to the presence of an infectious agent or agents or its toxin or toxins; and

b. That was not present or incubating at the time of admission to the

health-care

healthcare

facility.

(7)

(8)

“

Health-care

Healthcare

facility” means a correctional

healthcare

facility, dialysis center, freestanding surgical center, hospital, long-term care facility, or

psychiatric

behavioral health

facility.

(8)

(9)

“Hospital” means an acute care

health-care

healthcare

facility licensed under Chapter 10 of this title.

(9)

(10)

“Long-term care facility” means a nursing facility or intermediate care facility for persons with intellectual disabilities licensed under Chapter 11 of this title.

(11) “Public report” means the report provided to the

health-care

healthcare

facilities and the public by the Department as set forth in this chapter.

§ 1003A. Reporting of infections by physicians.

In accordance with this chapter, a physician who diagnoses and treats a

health-care

healthcare

associated infection related to a clinical procedure,

such as a surgical procedure or device insertion,

or a licensed practitioner who is permitted by law to diagnose and treat such infection and does so, is required to report the infection back to the

health-care

healthcare

facility at which the clinical procedure was performed. The infection

control

prevention

department of the

health-care

healthcare

facility will then be required to report to the Department only those infections that meet the accepted National Healthcare Safety Network definitions and are currently required to be reported by law.

§ 1004A. Hospital reports.

(a) Individual hospitals shall collect data on

health-care

healthcare

associated infection rates related to specific clinical procedures as determined by the Advisory Committee and set forth in regulations promulgated by the Department. Examples may include the following categories:

(1) Surgical site infections such as total hip and knee

arthroplasty;

arthroplasty, colostomy, or hysterectomy.

(2) Central

line-related

line-associated

bloodstream

infections in an intensive care unit (ICU);

infections.

(3) Direct

health-care provider’s

healthcare personnel

influenza vaccination

rates; and

rates.

(4) Other categories as provided under subsection (c) of this section.

(b) (1) Infection

control

prevention

professionals, or a designee, of hospitals shall submit quarterly reports on their

health-care

healthcare

associated infection rates to the Department using the accepted Centers for Disease Control and Prevention’s (CDC) National Healthcare Safety Network (NHSN) definitions. Prevention and control data related to quality measures will be based on nationally recognized and recommended standards that may include those developed by the CDC, Centers for Medicare and

Medicaid,

Medicaid Services

and/or

and

the Agency for Healthcare, Research and

Quality, to name a few.

Quality.

Data in quarterly reports must cover a period ending not earlier than 45 days prior to submission of the report. Quarterly reports shall be made available to each hospital 45 days after submittal to the Department for review by the hospitals. The hospitals shall have 7 days to review the quarterly reports and report any changes to the Department. Following the 7-day review period, such quarterly reports shall be made available to the public at each hospital and through the Department (the “public report”).

(2) If the hospital is a division or subsidiary of another entity that owns or operates other hospitals or related organizations, the quarterly report shall be for the specific division or subsidiary and not for the other entity.

(c)

After June 30, 2010,

The Department may revise categories of infections set forth in subsection (a) of this section

and

upon consultation with the Advisory Committee and other experts in infection, prevention, identification and

control, the Department may revise categories of infections set forth in subsection (a) of this section.

control.

§ 1005A. Department reports.

(a) The Department shall annually submit to the legislature a report summarizing the hospital quarterly reports and shall publish the annual report on its website.

The first annual report shall be published no later than June 30, 2009. Following the initial report, the

The

Department shall update the public information on a quarterly basis.

(b) All reports issued by the Department shall be

risk adjusted,

risk-adjusted

or use some other method to account for the differences in patient populations among hospitals.

(c) The annual report shall compare

health-care

healthcare

associated infection rates to national rates published by the CDC’s NHSN program and collected pursuant to this chapter for each individual hospital in the State. The Department, in consultation with the Advisory Committee, shall make this report as easy to comprehend as possible. The report shall also include an executive summary, written in plain language that shall include but not be limited to a discussion of findings, conclusions and trends concerning the overall state of

health-care

healthcare

associated infections in the State, including a comparison to prior years. The report may include policy recommendations, as appropriate.

(d) The Department shall publicize the report and its availability as widely as practical to interested parties, including but not limited to hospitals, providers, media organizations, health insurers, health maintenance organizations, purchasers of health insurance, organized labor, consumer or patient advocacy groups and individual consumers. The annual report shall be made available to any person upon request.

(e) No hospital report or Department disclosure may contain information identifying a patient, employee or licensed

health-care

healthcare

professional in connection with a specific infection incident.

(f) The annual report shall provide background information about each hospital which shall include: the hospital’s adult and pediatric populations, bed size, and specialty divisions; whether the hospital provides tertiary care; and whether the hospital is a teaching or a nonteaching institution. This background information shall be included in the public report.

(g) The annual report shall include a brief summary report to allow hospitals to comment on performance improvement and changes in patient population and risk factors. The information contained in the summary report shall be considered proprietary information and shall be utilized by the Department but shall not be made available in the public report and shall not be subject to disclosure under the State’s Freedom of Information Act (Chapter 100 of Title 29).

§ 1006A. Correctional facility reports.

(a) Correctional facilities shall collect data on

health-care

healthcare

associated infections related to specific clinical procedures resulting from care in the correctional facility, as determined by the Advisory Committee and as set forth in regulations promulgated by the Department. These categories of infection data may differ from that information required from hospitals.

(b) Correctional facilities shall report data to the Department in accordance with regulations of the Department. The information from the correctional facilities shall be segregated from the hospital data contained in the reports submitted pursuant to this chapter.

§ 1007A. Reports by other

health-care

healthcare

facilities.

Only with the concurrence of the Advisory Committee, and not until such time that the Centers for Medicaid and Medicare

Services

or the Centers for Disease Control and Prevention issue final federal regulations requiring such, and after careful evaluation of the economic and public health impact, the Department may through regulation require the reporting of

health-care

healthcare

associated infections from

health-care

healthcare

facilities other than hospitals and correctional facilities. The procedures for reporting shall be consistent with procedures for reporting by hospitals as specified in this chapter, except as may be necessary to accommodate the unique characteristics and capabilities of the

health-care

healthcare

facilities and the capabilities of the National Healthcare Safety Network.

§ 1008A. Advisory Committee.

(a) The Secretary of the Department shall appoint an Advisory Committee, which shall include:

(1)

1 infection control

One Infection prevention

professional who has responsibility for infection

control

prevention

programs for each hospital or

health-care

healthcare

system in

Delaware;

Delaware.

(2)

4

Three

infection disease physicians with expertise in infection

control;

prevention.

(3)

One representative of the Delaware Healthcare Association.

(4)

1

One

representative of the Delaware

Health Care

Healthcare

Facilities

Association;

Association.

(5)

1

One

representative of a freestanding surgical

center;

center.

(6) One infection preventionist representing Department of Correction healthcare facilities.

(7)

1

One

representative of a dialysis

center;

center.

(8)

1

One

representative of a

psychiatric

behavioral health

facility;

facility.

(9)

1

One

representative from the State Division of Public

Health; and

Health.

(10) One infection preventionist representing the State Division of Health Care

Quality; and

Quality.

(11)

the

The Division of

Public Health Healthcare Associated Infections Specialist responsible for collating and reporting data.

(b)

The Secretary shall also appoint

8 other

5

members of the Committee

including

including:

(1)

representatives from

One person representing

direct care nursing

staff,

staff.

(2)

One person representing

academic

researchers,

researchers.

(3)

One person representing a

consumer

organizations,

organization.

(4)

One person representing

health

insurers, health maintenance organizations, organized labor and purchasers of health insurance, such as employers.

i

nsurers.

(5)

One person representing population health organizations.

(c)

The Advisory Committee shall have the authority to engage personnel with appropriate training

and/or

and

certification in infection prevention and control for the purposes of collecting data

.

(b)

(d)

The Advisory Committee shall assist the Department in the development of all aspects of the Department’s methodology for collection, analyzing and disclosing the information collected under this chapter, including collection methods, formatting and methods and means for release and dissemination.

(c)

(e)

In developing the methodology for collecting and analyzing the infection rate data, the Department and the Advisory Committee shall adopt the methodologies and system for data collection from the Centers for Disease

Control’s

Control and Prevention’s

National Healthcare Safety Network, or its successor. The data collection and analysis methodology shall be disclosed to the public prior to any public disclosure of

health-care

healthcare

associated infection rates.

(d)

(f)

The Advisory Committee shall assist the Department in the sharing of information and best practices toward the development of activities and policies that:

(1) Enhance coordination between

health-care

healthcare

facilities throughout the continuum of care for the prevention and control of

health-care

healthcare

associated infections;

(2) Promote the prevention and control of

health-care

healthcare

associated infections generally; and

(3) Encourage the creation of benchmarks against which to measure progress in the prevention and control of

health-care

healthcare

associated infections.

§ 1009A. Privacy.

It is the express intent of the legislature that a patient’s right of confidentiality shall not be violated in any manner. Patient Social Security numbers and any other information that could be used to identify an individual patient shall not be released notwithstanding any other provision of law.

§ 1010A. Penalties.

A determination that a health-care facility has violated the provisions of this chapter may result in any of the following:

(1) Termination of licensure or other sanctions relating to licensure under Chapter 10 of this title; or

(2) A civil penalty of up to $500 per day per violation for each day the

health-care

healthcare

facility is in violation of this chapter.

§ 1011A. Regulatory oversight.

The Department shall be responsible for ensuring compliance. When the Department licenses a

health-care

healthcare

facility according to the provisions of this title, compliance with this chapter shall be a condition of licensure.

§ 1012A. Hospital Infection Specialist.

The Department shall establish and fund a Healthcare Associated Infection Specialist position within the Division of Public Health supporting the functions of this chapter. The Healthcare Associated Infection Specialist must have knowledge of the NHSN system and skills to appropriately analyze

health-care

healthcare

acquired infection data.

§ 1013A. Privilege and confidentiality protections.

Notwithstanding any other provision of federal, state or local law, the

health-care

healthcare

associated infection data provided pursuant to this chapter is privileged and,

with the exception of

except for

§§ 1003A, 1004A and 1005A of this title, shall not be:

(1) Subject to admission as evidence or other disclosure in any federal, state or local civil, criminal or administrative

proceeding, or

proceeding.

(2) Subject to use in a disciplinary proceeding against a

health-care

healthcare

facility or

provider, or

provider.

(3) Subject to disclosure under Chapter 100 of Title 29.

§ 1014A. Membership in National Healthcare Safety Network.

By December 31, 2007, all

All

hospitals in the State shall join the Centers of Disease Control and Prevention’s National Healthcare Safety Network or its successor. If the Network is not open for

enrollment to all hospitals by this date,

enrollment,

all hospitals shall join the Network within 180 days after the

Center

Centers

of Disease Control and Prevention permits such enrollment. Hospitals shall authorize the Department to have access to hospital-specific data contained in the National Healthcare Safety Network database consistent with the requirements of this chapter. With the concurrence of the Advisory Committee the Department may require other

health-care

healthcare

facilities through regulation to join the National Healthcare Safety Network as may be appropriate in accordance with this chapter.

SYNOPSIS

This Act updates Chapter 10A of Title 16, the Healthcare-Associated Infections Disclosure Act, to ensure consistency with correct terminology, such as psychiatric changes to behavioral health facilities and to adherence to Centers for Disease Control and Prevention (CDC) National Healthcare Safety Network (NHSN) requirements.

This Act also makes technical corrections to conform existing law to the standards of the Delaware Legislative Drafting Manual.